Related Experiment Video
Updated: Jun 6, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Palliative care in advanced systemic rheumatic diseases: an integrated approach
Adam Amlani1, Kirsten Wentlandt2,3, Alexandra P Saltman4,5,6
1University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
This guide helps palliative care physicians manage rheumatoid arthritis in patients with life-limiting illness. It focuses on the systemic aspects and end-of-life medication management for rheumatic diseases.
Area of Science:
- Rheumatology
- Palliative Care
- Systemic Rheumatic Diseases
Background:
- Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease causing significant morbidity and reduced life expectancy.
- Despite advances in rheumatology, many RA patients experience a high symptom burden, particularly those with life-limiting illness.
Purpose of the Study:
- To provide a guide for palliative care physicians managing patients with rheumatoid arthritis and life-limiting illness.
- To address the systemic nature of RA and specific medication management challenges at the end of life.
Main Methods:
- Review of current literature on rheumatoid arthritis management in palliative care.
- Case study approach focusing on end-of-life medication adjustments for RA.
Main Results:
- Identification of key considerations for managing systemic rheumatic disease in end-of-life care.
- Strategies for optimizing medication regimens to reduce morbidity.
Conclusions:
- Palliative care requires a nuanced approach to managing rheumatoid arthritis, considering its systemic effects.
- Effective end-of-life medication management can decrease morbidity associated with rheumatic diseases and their treatments.
Related Concept Videos
Rheumatic Heart Disease IV: Nursing Management
Continuing Care
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Chronic Pancreatitis II: Collaborative Care
Assessment:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

